PMID: 11906388Mar 22, 2002Paper

Treatment of the axilla in early breast cancer: past, present and future

ANZ Journal of Surgery
B ChuaJ Boyages

Abstract

The optimal treatment of the axilla in early breast cancer is controversial. The present study reviews the pattern and predictors of regional recurrence (RR) and prognosis after RR in patients with early breast cancer treated by conservative surgery and radiotherapy (CS + RT). Implications of the results on current practice and future directions are explored. Between 1979 and 1994, 1158 patients with stage I or II breast cancer were treated with CS + RT at Westmead Hospital. Two groups of patients were compared: 782 patients who underwent axillary dissection (axillary surgery group) and 229 patients who received radiotherapy (axillary RT group) as the only axillary treatment. At least 10 lymph nodes were dissected in 82% of the axillary surgery group. Of the women in the RT group, 90% received RT to the axilla and supraclavicular fossa (SCF) only and 10% also received RT to the internal mammary chain (IMC). With a median follow-up period of 79 months for the axillary surgery group and 111 months for the axillary RT group, 27 patients developed a RR (2.8% and 2.2%, respectively). Seven patients (0.9%) in the axillary surgery group and three patients (1.3%) in the axillary RT group developed a RR in the axilla (P, not significant...Continue Reading

References

Oct 1, 1992·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·A Recht
Jan 1, 1992·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·C K AxelssonK Zedeler
Jan 26, 1991·Lancet·I S Fentiman, R E Mansel
May 4, 1991·Lancet·A M NevilleA Goldhirsch
Jun 1, 1991·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A RechtJ R Harris
Oct 1, 1990·International Journal of Radiation Oncology, Biology, Physics·B G HafftyJ J Fischer
Mar 1, 1990·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R GelmanJ R Harris
Oct 1, 1989·International Journal of Radiation Oncology, Biology, Physics·B FowbleR L Goodman
Jul 1, 1989·International Journal of Radiation Oncology, Biology, Physics·G H FletcherM J Oswald
Apr 1, 1988·International Journal of Radiation Oncology, Biology, Physics·M R BaezaJ Cornejo
Apr 1, 1987·International Journal of Radiation Oncology, Biology, Physics·J A DewarG Contesso
Jun 1, 1986·International Journal of Radiation Oncology, Biology, Physics·R CalleA Fourquet
Aug 1, 1986·The British Journal of Surgery·D SarrazinT Le Chevalier
Jul 1, 1986·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·B PierquinD Glaubiger
Jan 1, 1987·International Journal of Radiation Oncology, Biology, Physics·G DeloucheJ M Kurtz
Jan 1, 1987·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·E van LimbergenA Rijnders
Oct 1, 1985·World Journal of Surgery·U VeronesiM Del Vecchio
Jan 1, 1986·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·S LeungB Pierquin
Jan 1, 1985·Breast Cancer Research and Treatment·J R Harris, R T Osteen
Nov 1, 1981·Annals of Surgery·P P RosenD W Kinne
Dec 1, 1982·The British Journal of Surgery·J P Lythgoe, M K Palmer
Nov 30, 1995·The New England Journal of Medicine·UNKNOWN Early Breast Cancer Trialists' Collaborative Group
Sep 1, 1994·Annals of Surgery·A E GiulianoD L Morton
Aug 1, 1993·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P P LinR R Baker
May 1, 1997·Journal of Surgical Oncology·D A FeinB L Eisenberg
Jun 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A E GiulianoR Statman
Oct 2, 1997·The New England Journal of Medicine·J RagazI A Olivotto
Mar 4, 1998·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·R M RoumenL M Geuskens
Apr 17, 1998·Journal of the American College of Surgeons·B J O'HeaH S Cody
Aug 6, 1998·The British Journal of Surgery·M M FlettT G Cooke
Oct 22, 1998·The British Journal of Surgery·S A McIntosh, A D Purushotham
Feb 2, 1999·American Journal of Surgery·F E NwariakuG N Peters

❮ Previous
Next ❯

Citations

Mar 17, 2004·The Breast : Official Journal of the European Society of Mastology·Maged Hussien, R A J Spence
Mar 30, 2017·Revista da Associação Médica Brasileira·Régis Resende PaulinelliTatiane Coelho Capel de Resende
May 25, 2006·The Oncologist·Merih Guray, Aysegul A Sahin
Dec 12, 2013·Obstetrics & Gynecology Science·Ji Hoon YuTae-Gyu Ahn

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.